1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Malaria Vaccines Market
2.3. Global Malaria Vaccines Market, By Target, 2025 (US$ Million)
2.4. Global Malaria Vaccines Market, By Strain, 2025 (US$ Million)
2.5. Global Malaria Vaccines Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Malaria Vaccines Market: Competitive Analysis
3.1. Market Positioning of Key Malaria Vaccines Market Vendors
3.2. Strategies Adopted by Malaria Vaccines Market Vendors
4. Malaria Vaccines Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Malaria Vaccines Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Pre-erythrocytic
5.3.2. Transmission Blocking
5.3.3. Blood Stage
6. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Plasmodium Falciparum
6.3.2. Plasmodium Vivax
7. North America Malaria Vaccines Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
7.3. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
7.4. Malaria Vaccines Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
7.4.1.1.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
7.4.1.2.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
7.4.1.3.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8. UK and European Union Malaria Vaccines Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.3. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4. Malaria Vaccines Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.1.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.2.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.3.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.4.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.5.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
8.4.1.6.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9. Asia Pacific Malaria Vaccines Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.3. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4. Malaria Vaccines Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.1.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.2.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.3.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.4.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.5.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
9.4.1.6.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
10. Latin America Malaria Vaccines Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
10.3. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
10.4. Malaria Vaccines Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
10.4.1.1.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
10.4.1.2.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
10.4.1.3.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
11. Middle East and Africa Malaria Vaccines Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
11.3. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
11.4. Malaria Vaccines Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
11.4.1.1.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
11.4.1.2.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Malaria Vaccines Market: By Target, 2024-2034, USD (Million)
11.4.1.3.2. Malaria Vaccines Market: By Strain, 2024-2034, USD (Million)
12. Company Profile
12.1. Nobelpharma Co., Ltd. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. GenVec, Inc.
12.3. Sumaya Biotech
12.4. Others
